Its a good question that i think we need to ask the company. My understanding is smn did the testing using our equipment, so we are now available to do a new application. I also thought the benefit compounded on a plane, so the more applications it has shows exponential benefit. But this could well be wrong, i can't find the evidence to back up my statement and i like a drink, so memory is shot.
SMN - Chart, page-3159
Featured News
Add SMN (ASX) to my watchlist
(20min delay)
|
|||||
Last
48.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $71.28M |
Open | High | Low | Value | Volume |
49.0¢ | 49.5¢ | 48.0¢ | $33.82K | 69.11K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 1555 | 48.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
50.0¢ | 2500 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 1555 | 0.485 |
2 | 23000 | 0.480 |
2 | 25000 | 0.475 |
1 | 1500 | 0.470 |
2 | 17171 | 0.465 |
Price($) | Vol. | No. |
---|---|---|
0.500 | 8951 | 2 |
0.510 | 326 | 1 |
0.515 | 13182 | 1 |
0.520 | 72780 | 2 |
0.525 | 21886 | 1 |
Last trade - 15.37pm 15/11/2024 (20 minute delay) ? |
Featured News
SMN (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online